Roderick van den Bergh/prostaatkankerstichting.nl
Dec 2, 2024, 22:38
Gleason score 6 – Should we keep calling it cancer?
Bárbara Melão, Urologist in Oncology Department, Manaus Adventist Hospital, shared a post on X:
“PROSCA24. Gleason score 6: should we keep calling it cancer?
Presenter: Roderick van den Bergh
- No But we need surveillance
- It doesn’t metastasize
- 14% upgrading 1
- 2-24% true progression
- Use of risk factors could estimate the risk of true cancer.”
For more updates, follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 16:16
Feb 22, 2025, 16:04
Feb 22, 2025, 16:00
Feb 22, 2025, 15:54
Feb 22, 2025, 15:48
Feb 22, 2025, 15:33
Feb 22, 2025, 15:14
Feb 22, 2025, 15:04
Feb 22, 2025, 14:43
Feb 22, 2025, 14:10
Feb 22, 2025, 13:28
Feb 22, 2025, 13:10